The Journal of Urology® contains 4 sections: Adult Urology, Pediatric Urology,
Investigative Urology and Urological Survey. Rapid Communications are welcomed.
The Clinical Section usually does not publish
laboratory animal
studies. The Investigative Section does not publish clinically oriented articles,
and does not require prior
approval for Review Articles. Unsolicited material is
not accepted for Urological Survey.
Submission of single case
reports is discouraged. The decision to
publish a single case report will be based on its relevance to advancing
the practice of urology.
All communications concerning editorial matters should be sent to:
The Journal of Urology®
Publications
Department
American Urological Association
1000 Corporate Boulevard
Linthicum, MD 21090
Telephone (410) 689-3922, FAX
(410) 689-3906
e-mail: publications@auanet.org
MANUSCRIPT SUBMISSION. Authors must submit their manuscripts
through the Web-based tracking system at https://www.editorialmanager.com/ju . The site contains instructions and advice
on how to use the system,
guidance on the creation/scanning and saving of electronic art, and supporting
documentation. In addition to
allowing authors to submit manuscripts on the
Web, the site allows authors to follow the progression of their manuscript
through the
peer review process. Authors are asked NOT to mail hard copies
of the manuscript to the editorial office. They may, however, mail
to the
editorial office any material that cannot be submitted electronically.
For potentially acceptable manuscripts, the period
between receipt
of all reviews and when an editorial decision is made is usually
longer.
AUTHOR'S RESPONSIBILITY.
Manuscripts must be accompanied by a
cover letter, an AUA
Disclosure Form and an Author
Submission Requirement Form
(see last page) signed by all authors. The letter should include the complete
address, telephone
number, FAX number and e-mail address of the designated
corresponding author as well as the names of potential reviewers. The corresponding
author is responsible for indicating the source of extra-institutional
funding, in particular that provided by commercial sources, internal
review
board approval of study, accuracy of the references and all statements made in
their work, including changes made by the copy
editor.
Manuscripts submitted without all signatures on all statements
will be returned to the authors immediately. Electronic
signatures are
acceptable.
Authors are expected to submit complete and correct manuscripts. Due to
the large number of high
quality articles being submitted and to avoid significant
delay in publication, the Editors find it necessary to insist that the
length
of manuscripts, and number of references and illustrations conform to
the requirements indicated herein. No paper will be reviewed until
these
requirements are met. Published manuscripts become the sole property of The
Journal of Urology® and copyright
will be taken out in the name of the
American Urological Association Education and Research, Inc.
All accepted NIH funded articles
must be directly deposited to
PubMed Central by the authors of the article for public access 12
months after the publication date.
PAGE PROOFS AND CORRECTIONS. The corresponding author will
receive electronic page proofs to check the typeset article before
publication.
Portable document format (PDF) files of the typeset pages and support documents
(eg, reprint order form) will be sent to
the corresponding author by
e-mail. Complete instructions will be provided with the e-mail for downloading
and printing the files and
for faxing the corrected page proofs to the
editorial office.
It is the author's responsibility to ensure that there are no errors
in the
proofs. Changes that have been made to conform to journal style will stand if
they do not alter the author's meaning. Only the
most critical changes to the
accuracy of the content will be made. Changes that are stylistic or are a
reworking of previously accepted
material will be disallowed. The editorial
office reserves the right to disallow extensive alterations. Authors may be
charged for alterations
to the proofs beyond those required to correct errors or
to answer queries. Proofs must be checked carefully and corrections faxed
within
24 to 48 hours of receipt, as requested in the cover letter accompanying
the page proofs.
Rapid Review Manuscripts that contain
important and timely information
will be reviewed by 2 consultants and the editors within 72 hours of
receipt, and authors will be notified
of the disposition immediately thereafter.
A $250 processing fee should be forwarded with the manuscript at the
time of submission.
Checks should be made payable to the American Urological
Association. If the editors decide that the paper does not warrant rapid
review,
the fee will be returned to the authors, and they may elect to have the
manuscript continue through the standard review process. Payment
for rapid
review guarantees only an expedited review and not acceptance.
Original, Research and Special Articles should be
arranged as follows:
Title Page, Abstract, Introduction, Materials and Methods, Results,
Discussion, Conclusions, References, Tables,
Legends. The title page should
contain a concise, descriptive title, the names and affiliations of all authors,
and a brief descriptive
runninghead not to exceed 50 characters. One to five
key words should be typed at the bottom of the title page. These words should
be
identical to the medical subject headings (MeSH) that appear in the Index
Medicus of the National Library of Medicine. The abstract should
not exceed
250 words and must conform to the following style: Purpose, Materials and
Methods, Results and Conclusions.
References
should not exceed 30 readily available citations for all articles
(except Review Articles). Self-citations should be kept to a minimum.
References should be cited by superscript numbers as they appear in the text,
and they should not be alphabetized. References should
include the names
and initials of the first 3 authors, the complete title, the abbreviated journal
name according to the Index Medicus
of the National Library of Medicine, the
volume, the beginning page number and the year. References to book chapters
should include names
and initials of the first 3 chapter authors, chapter title,
book title and edition, names and initials of the first 3 book editors, city
of
publisher, publisher, volume number, chapter number, page range and year.
In addition to the above, references to electronic publications
should include
type of medium, availability statement and date of accession. The statistical
methods should be indicated and referenced.
Enough information should be
presented to allow an independent critical assessment of the data.
Digital illustrations and tables should be kept to a necessary minimum
and their information should not be duplicated in the text. No more than
10 illustrations should
accompany the manuscript for clinical articles. Magnifications
for photomicrographs should be supplied and graphs should be
labeled clearly.
Reference to illustrations, numbered with Arabic numerals,
must be provided in the text. Blurry or unrecognizable illustrations are not
acceptable. Visit http://rapidinspector.cadmus.com/zww for detailed instructions
for digital art. The use of color is
encouraged at no charge to the
authors. Tables should be numbered and referred to in the text. In general,
they should present summarized
rather than individual raw data.
Letters to the Editor should be useful to urological practitioners. The
length should not
exceed 500 words. Only Letters concerning articles published
in the Journal within the last year are considered.
Review Articles
should not be submitted without prior approval. Queries
for these articles should be accompanied by a detailed outline of the
proposed
article, an abstract not to exceed 750 words and an estimate of the
length of the manuscript to be submitted. The format is the same
as that of an
Original Article.
Special Articles are scientific reports of original clinical research and
state-of-the-art
topics.
Opposing Views are submitted by invitation only.
Video Clips may be submitted for posting on The Journal
web site. They
are subject to peer review. Video files must be compressed to the smallest
possible size that still allows for high resolution
and quality presentation. The
size of each clip should not exceed 10MB. File size limitation is intended to
ensure that end-users are
able to download and view files in a reasonable time
frame. If files exceed the specified size limitation, they will not be posted to
the
web site and returned to the author for resubmission. For complete instructions
e-mail:publications@auanet.org.
Recommendations
1. All subgroup analyses and covariate inclusions should be motivated prior to the Results section. Hypotheses which were not
established
prior to initial analyses should be clearly identified. 2. Variables should be clearly defined, such as specific assays, references
for staging, references for validation of survey
instruments, etc. 3. Treatment regimens should be described well enough for another
study to replicate. 4. It should be clear which statistical test is associated with each p value reported. 5. Rarely used statistical
techniques should be described. 6. Medians and percentiles (such as quartiles) are preferred over means and standard deviations (or
standard errors) when
analyzing asymmetric data, especially when nonparametric statistics are calculated. 7. Fractions (eg, 5/10)
should accompany percentages. 8. In randomized clinical trials, consider reporting separate analyses with confounding variables included.
9. If sample sizes differ between groups when patients are randomized, reasons should be provided.
10. Report median survival (using
Kaplan-Meier) rather than mean survival if any data are censored. 11. Comparing survival functions (eg, with a log rank test) is
more efficient than analyzing particular time estimates (eg, 5-year
survival).
12. Use appropriate figures. Scatter plots are useful
for illustrating important correlations between variables. If subjects are
repeated in a figure (eg, over time), an individual's set
of points should be joined with line segments. Different symbols should
be used when points are stacked on top of each other. Illustrations
of regression lines should be overlaid on raw data.
Regression lines should not extend beyond the range of the predictor variable. 13.
Confidence intervals are more appropriate than standard errors for comparison of groups. 14. Use appropriate tables. Coefficients
and standard errors are useful for interpreting regression predictors. One significant
figure beyond the level measured is sufficient
for means, standard deviations, standard errors, etc. One decimal place for
percentages greater than 1% is sufficient; no decimal places
if the sample size is less than 100. Two significant figures for test
statistics and p values are sufficient. Means should generally
be accompanied by some measure of their uncertainty, such as
confidence intervals or standard errors. 15. Confidence intervals should
be reported when possible. 16. When a statistical hypothesis test is not rejected, the actual p value (eg, 0.07) should be reported
(if known) rather than omitted
or reported as p >0.05. 17. Pay close attention to wording. The word 'correlation' is generally
reserved for computing correlation coefficients. The word
'association' is usually preferred. Statistical tests can be nonparametric;
data cannot. Studies with negative findings (ie, no
difference) may be the result of low statistical power (eg, small sample size), rather
than absence of a difference, and this
limitation should be made clear. Trends that are not statistically significant should not be identified.
A p value is the
probability of observing data as extreme as those reported if the null hypothesis of no difference is true. A p value
is not the
probability of no real effect, nor is it necessarily related to the clinical importance.
Manuscript Checklist
• 1. Author Submission
Requirement form has been signed by all authors. • 2. AUA
Disclosure Form has been signed by all authors. • 3. Manuscript word count is provided. • 4. Manuscript
does not exceed 2,500 words for Original Article. • 5. Manuscript does not exceed 3,000 words for Research or Special Article.
• 6. Manuscript does not exceed 500 words for Letter to the Editor. • 7. Manuscript does not exceed 1,000 words for
Opposing Views. • 8. No more than 10 illustrations submitted. • 9. Standard abbreviations are defined in a key at
the end of the manuscript, and are consistent throughout the text. • 10. Generic names are used for all drugs. Trade names
are avoided. • 11. Normal laboratory values are provided in parentheses when first used. • 12. The number of authors
is limited to 6; if more than that number the senior author has justified their inclusion of each
individual. • 13. Research
or project support/funding is noted. • 14. Internal review board approval of study is indicated. • 15. References
are accurate, complete and in numerical order as they appear in the text, only the first 3 authors are listed. • 16. No more
than 30 references are cited, including references from the last 3 years; if more than that number the senior
author has justified their
inclusion. • 17. A corresponding author and complete address, telephone and FAX numbers and e-mail address are provided.
• 18. Written permission from publishers to reproduce or adapt previously published illustrations or tables is included. •
19. Informed consent forms for identifiable patient descriptions, photographs and pedigrees are included. • 20. Analytical
reporting checklist completed. • 21. Gender and minorities are identified in collection and analyses of data. • 22.
Abbreviations for human genes are written in italicized capital letters; protein products are written in capital letters and
are not
italicized. • 23. Abbreviations for animal genes are written in italics with only the first letter capitalized; protein products
are written with
only the first letter capitalized and are not italicized.
